Enantioselectivity in some physiological and pathophysiological roles of hydroxyeicosatetraenoic acids

Abstract

The phenomenon of chirality has been shown to greatly impact drug activities and effects. Different enantiomers may exhibit different effects in a certain biological condition or disease state. Cytochrome P450 (CYP) enzymes metabolize arachidonic acid (AA) into a large variety of metabolites with a wide range of activities. Hydroxylation of AA by CYP hydroxylases produces hydroxyeicosatetraenoic acids (HETEs), which are classified into mid-chain (5, 8, 9, 11, 12, and 15-HETE), subterminal (16-, 17-, 18- and 19-HETE) and terminal (20-HETE) HETEs. Except for 20-HETE, these metabolites exist as a racemic mixture of R and S enantiomers in the physiological system. The two enantiomers could have different degrees of activity or sometimes opposing effects. In this review article, we aimed to discuss the role of mid-chain and subterminal HETEs in different organs, importantly the heart and the kidneys. Moreover, we summarized their effects in some conditions such as neutrophil migration, inflammation, angiogenesis, and tumorigenesis, with a focus on the reported enantiospecific effects. We also reported some studies using genetically modified models to investigate the roles of HETEs in different conditions.

Keywords:

• CYP
• Arachidonic acid
• hydroxyeicosatetraenoic acids
• heart
• kidney

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

A.O.S.E-K. was supported by [CIHR PS 168846]. S.H. is the recipient of the Egyptian Government Scholarship. S.H.G is the recipient of Alberta Innovates Graduate Student Scholarship.